首页 › 基金 › Verdad Advisers, LP › XFOR
Verdad Advisers, LP 对 XFOR 的持仓历史
X4 PHARMACEUTICALS INC · 医疗保健
Verdad Advisers, LP 在 Q3 2026 的 13F 申报中披露持有 XFOR(X4 PHARMACEUTICALS INC)323,166 股,市值约 US$937K,约占其申报组合的 1.01%,在其申报持仓中市值排名第 26 位。 Verdad Advisers, LP 最近 2 个申报季度中有 2 个季度披露了 XFOR 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Verdad Advisers, LP 对 XFOR 的持仓演变
Verdad Advisers, LP 于 Q2 2026 首次披露 XFOR 持仓:352,093 股(约 US$1.6M)。 在 2 次申报中,Verdad Advisers, LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 323,166 股、市值约 US$937K,环比减持 -28,927 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 352.09K | $1.64M | 新进 |
| Q3 2026 | 323.17K | $937.18K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 XFOR 与 13F 数据
XFOR(X4 PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 XFOR,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$37.0M), Empery Asset Management, LP (US$28.2M), Bain Capital Life Sciences Investors, LLC (US$23.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 XFOR 的基金
- PERCEPTIVE ADVISORS LLC 7.93M 股 · $37.05M · Q2 2026
- Empery Asset Management, LP 9.73M 股 · $28.20M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 7.97M 股 · $23.11M · Q3 2026
- Saturn V Capital Management LP 7.37M 股 · $21.36M · Q3 2026
- NEA Management Company, LLC 3.23M 股 · $15.10M · Q2 2026
- Kalehua Capital Management LLC 3.72M 股 · $10.80M · Q3 2026
- BVF INC/IL 2.23M 股 · $10.43M · Q2 2026
- Rosalind Advisors, Inc. 3.21M 股 · $9.32M · Q3 2026
- Venrock Adviser, LLC 1.93M 股 · $9.03M · Q2 2026
- Trails Edge Capital Partners, LP 2.57M 股 · $7.46M · Q3 2026
- Samsara BioCapital, LLC 1.40M 股 · $6.52M · Q2 2026
更多关于 Verdad Advisers, LP
常见问题
How long has Verdad Advisers, LP held XFOR?
Verdad Advisers, LP has disclosed XFOR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Verdad Advisers, LP's current position in XFOR?
As of Q3 2026, Verdad Advisers, LP holds 323.17K shares of XFOR (X4 PHARMACEUTICALS INC), valued at $937.18K, representing 1.01% of its reported portfolio and ranking #26.
Has Verdad Advisers, LP been buying or selling XFOR?
In the latest 13F filing (Q3 2026), Verdad Advisers, LP reduced its position in XFOR.
Which other funds hold XFOR?
Other major institutional holders of XFOR include PERCEPTIVE ADVISORS LLC, Empery Asset Management, LP, Bain Capital Life Sciences Investors, LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.